Collaboration catalyzes industry progress| Wyss InstituteWyss Institute
Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy| Wyss InstituteWyss Institute
Breakthrough aims to shorten the time women wait for effective treatment from an average of five years to just five months| Wyss InstituteWyss Institute
By Alexandra Jirstrand (BOSTON) – The Wyss Institute at Harvard University, its Board of Directors, and Executive Leadership are pleased to announce that Natalie Artzi, Ph.D., has been appointed to a newly created position as Associate Institute Director of the Wyss Institute. In her new role, Artzi will work closely with the Wyss Founding Director...| Wyss Institute